u/Old_Celebration279

Image 1 — Portfolio went from ₹30L to ₹50L+ in 3 months. No fresh capital added.
Image 2 — Portfolio went from ₹30L to ₹50L+ in 3 months. No fresh capital added.

Portfolio went from ₹30L to ₹50L+ in 3 months. No fresh capital added.

Just wanted to share my last 3 months portfolio journey.

On 30th March, my portfolio was around ₹29.28L.
By early July, it crossed ₹50.17L.

Before anyone says “you must have added more money”, I didn’t add even a single rupee of fresh capital during this period.

The invested value changed because I booked profits in some stocks and rotated that money into newer opportunities. So it may look like fresh investment, but it is basically recycled capital from profit-booking and reinvestment.

My portfolio XIRR is currently around 35%+, while the benchmark shown there, NIFTY Smallcap 250, is around 8.23%.

The biggest reason this happened was concentration. I usually hold only 8-10 stocks max, and I try to stay focused on strong catalysts instead of spreading money across 25-30 names.

Some stocks that really helped during this period were names like Sterlite Tech, Sky Gold, Suven, Wock and a few other small-cap moves that played out strongly after March.

Of course, this also works both ways. A concentrated portfolio can make your returns look beautiful when you are right, but it can also punch you in the face when you are wrong. So I’m not saying this is the best strategy for everyone.

u/Old_Celebration279 — 2 days ago

Wockhardt is now officially a Rocket 🚀

Wockhardt’s Zaynich is no longer just a “future story” now.

India CDSCO approval + US FDA approval means this antibiotic has crossed two major regulatory gates. This is India-born innovation going after drug-resistant superbug infections, a space where the unmet need is massive.

u/Old_Celebration279 — 1 month ago

Anybody else gearing up for Zaynich’s global approval? Wock

Zaynich got just approved today by Indian Regulators that explains the rally earlier this week for Wock.

Now waiting for the BIG BIG fish i.e FDA which is due to come anytime after 10 June.

I have taken my position and sitting tight for the next leg 🤞

u/Old_Celebration279 — 1 month ago

Feels good when your analysis outperforms your own expectations!!

I recommended these stocks and ofcourse bought them myself at much lower prices a month ago.

Come to today and all of these literally have blown away and exceeded my maths.

I sold Sterlite completely now because I sense a liquidity trap there, I might re-enter again at 300-310 levels but for now it’s too much for me and have already booked 100% gains in it so not complaining.

Now my next target is Wockhardt, Suven & Insolation energy which I am holding them and quite heavily concentrated at into these three atm.

Let me know your thoughts and what do you think of my picks.

u/Old_Celebration279 — 2 months ago

If all goes well by Mid june wockhardt may become the darling stock of 2026.

Data reveals a probability of 80% approval chances so I am really risking my capital here and dont wanna be underinvested once the approval comes this month.

u/Old_Celebration279 — 2 months ago

In anticipation of May announcement I started buying Suven aggressively from Feb/March window and now as the result date is coming close stock has given me almost 50% gains already. But I am hoping if they announce positive scores/results that are due in May sometime another 40/50% would be a cake walk. Anyone else closely watching this biotech play?

u/Old_Celebration279 — 2 months ago